Emyria (ASX:EMD) has been featured on investment strategy podcast, Equity Mates.
In discussion with Bryce Leske and Alec Renehan, CEO and MD, Dr Michael Winlo, provides in-depth analysis into the scientific merits of MDMA-Assisted Therapy and in particular, Emyria’s smart clinical business model underpinning its future accessibility and scalability in market.
Have a listen: